Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
74
FBT.TO Quote, Financials, Valuation and Earnings
Last price:
$36.99
Seasonality move
:
3.78%
Day range:
$37.00 - $37.00
52-week range:
$25.84 - $37.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
112
1-year change:
24.09%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | -- | -- | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
$36.99 | -- | -- | -- | $0.00 | 0% | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
$42.74 | -- | -- | -- | $0.01 | 0.07% | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
$22.25 | -- | -- | -- | $0.09 | 0% | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
$37.77 | -- | -- | -- | $0.16 | 0.45% | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
$44.87 | -- | -- | -- | $0.25 | 0.56% | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
$70.16 | -- | -- | -- | $0.49 | 0.69% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | 1.195 | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | 1.354 | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | 0.000 | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | 1.166 | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | 1.183 | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | 1.194 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FBT.TO
First Trust NYSE Arca Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
FHH.TO
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX.TO
Global X Eq Wght Global Healthcare idx ETF Cl A
|
-- | -- | -- | -- | -- | -- |
|
XDNA.TO
iShares Genomics Immunology and Healthcare Idx ETF
|
-- | -- | -- | -- | -- | -- |
|
ZHU.TO
BMO Equal Weight US Health Care Indx ETF
|
-- | -- | -- | -- | -- | -- |
|
ZUH.TO
BMO Equal Weight US Health Care Hgd to CAD Idx ETF
|
-- | -- | -- | -- | -- | -- |
First Trust NYSE Arca Biotechnology ETF vs. Competitors
-
Which has Higher Returns FBT.TO or FHH.TO?
First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology ETF's net margin of --. First Trust NYSE Arca Biotechnology ETF's return on equity of -- beat First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- -
What do Analysts Say About FBT.TO or FHH.TO?
First Trust NYSE Arca Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology ETF has higher upside potential than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF, analysts believe First Trust NYSE Arca Biotechnology ETF is more attractive than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF0 0 0 -
Is FBT.TO or FHH.TO More Risky?
First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, which suggesting that the stock is 39.708% less volatile than S&P 500. In comparison First Trust AlphaDEX™ US Hlth Care Sector Idx ETF has a beta of 0.699, suggesting its less volatile than the S&P 500 by 30.053%.
-
Which is a Better Dividend Stock FBT.TO or FHH.TO?
First Trust NYSE Arca Biotechnology ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.01 per share. First Trust NYSE Arca Biotechnology ETF pays -- of its earnings as a dividend. First Trust AlphaDEX™ US Hlth Care Sector Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT.TO or FHH.TO?
First Trust NYSE Arca Biotechnology ETF quarterly revenues are --, which are smaller than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology ETF's net income of -- is lower than First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology ETF's price-to-earnings ratio is -- while First Trust AlphaDEX™ US Hlth Care Sector Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology ETF is -- versus -- for First Trust AlphaDEX™ US Hlth Care Sector Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -- FHH.TOFirst Trust AlphaDEX™ US Hlth Care Sector Idx ETF-- -- -- --
-
Which has Higher Returns FBT.TO or MEDX.TO?
Global X Eq Wght Global Healthcare idx ETF Cl A has a net margin of -- compared to First Trust NYSE Arca Biotechnology ETF's net margin of --. First Trust NYSE Arca Biotechnology ETF's return on equity of -- beat Global X Eq Wght Global Healthcare idx ETF Cl A's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A-- -- -- -
What do Analysts Say About FBT.TO or MEDX.TO?
First Trust NYSE Arca Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Eq Wght Global Healthcare idx ETF Cl A has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology ETF has higher upside potential than Global X Eq Wght Global Healthcare idx ETF Cl A, analysts believe First Trust NYSE Arca Biotechnology ETF is more attractive than Global X Eq Wght Global Healthcare idx ETF Cl A.
Company Buy Ratings Hold Ratings Sell Ratings FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A0 0 0 -
Is FBT.TO or MEDX.TO More Risky?
First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, which suggesting that the stock is 39.708% less volatile than S&P 500. In comparison Global X Eq Wght Global Healthcare idx ETF Cl A has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FBT.TO or MEDX.TO?
First Trust NYSE Arca Biotechnology ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Eq Wght Global Healthcare idx ETF Cl A offers a yield of 0% to investors and pays a quarterly dividend of $0.09 per share. First Trust NYSE Arca Biotechnology ETF pays -- of its earnings as a dividend. Global X Eq Wght Global Healthcare idx ETF Cl A pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT.TO or MEDX.TO?
First Trust NYSE Arca Biotechnology ETF quarterly revenues are --, which are smaller than Global X Eq Wght Global Healthcare idx ETF Cl A quarterly revenues of --. First Trust NYSE Arca Biotechnology ETF's net income of -- is lower than Global X Eq Wght Global Healthcare idx ETF Cl A's net income of --. Notably, First Trust NYSE Arca Biotechnology ETF's price-to-earnings ratio is -- while Global X Eq Wght Global Healthcare idx ETF Cl A's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology ETF is -- versus -- for Global X Eq Wght Global Healthcare idx ETF Cl A. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -- MEDX.TOGlobal X Eq Wght Global Healthcare idx ETF Cl A-- -- -- --
-
Which has Higher Returns FBT.TO or XDNA.TO?
iShares Genomics Immunology and Healthcare Idx ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology ETF's net margin of --. First Trust NYSE Arca Biotechnology ETF's return on equity of -- beat iShares Genomics Immunology and Healthcare Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- -
What do Analysts Say About FBT.TO or XDNA.TO?
First Trust NYSE Arca Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Genomics Immunology and Healthcare Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology ETF has higher upside potential than iShares Genomics Immunology and Healthcare Idx ETF, analysts believe First Trust NYSE Arca Biotechnology ETF is more attractive than iShares Genomics Immunology and Healthcare Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF0 0 0 -
Is FBT.TO or XDNA.TO More Risky?
First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, which suggesting that the stock is 39.708% less volatile than S&P 500. In comparison iShares Genomics Immunology and Healthcare Idx ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FBT.TO or XDNA.TO?
First Trust NYSE Arca Biotechnology ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iShares Genomics Immunology and Healthcare Idx ETF offers a yield of 0.45% to investors and pays a quarterly dividend of $0.16 per share. First Trust NYSE Arca Biotechnology ETF pays -- of its earnings as a dividend. iShares Genomics Immunology and Healthcare Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT.TO or XDNA.TO?
First Trust NYSE Arca Biotechnology ETF quarterly revenues are --, which are smaller than iShares Genomics Immunology and Healthcare Idx ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology ETF's net income of -- is lower than iShares Genomics Immunology and Healthcare Idx ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology ETF's price-to-earnings ratio is -- while iShares Genomics Immunology and Healthcare Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology ETF is -- versus -- for iShares Genomics Immunology and Healthcare Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -- XDNA.TOiShares Genomics Immunology and Healthcare Idx ETF-- -- -- --
-
Which has Higher Returns FBT.TO or ZHU.TO?
BMO Equal Weight US Health Care Indx ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology ETF's net margin of --. First Trust NYSE Arca Biotechnology ETF's return on equity of -- beat BMO Equal Weight US Health Care Indx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- ZHU.TOBMO Equal Weight US Health Care Indx ETF-- -- -- -
What do Analysts Say About FBT.TO or ZHU.TO?
First Trust NYSE Arca Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BMO Equal Weight US Health Care Indx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology ETF has higher upside potential than BMO Equal Weight US Health Care Indx ETF, analysts believe First Trust NYSE Arca Biotechnology ETF is more attractive than BMO Equal Weight US Health Care Indx ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 ZHU.TOBMO Equal Weight US Health Care Indx ETF0 0 0 -
Is FBT.TO or ZHU.TO More Risky?
First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, which suggesting that the stock is 39.708% less volatile than S&P 500. In comparison BMO Equal Weight US Health Care Indx ETF has a beta of 0.698, suggesting its less volatile than the S&P 500 by 30.154%.
-
Which is a Better Dividend Stock FBT.TO or ZHU.TO?
First Trust NYSE Arca Biotechnology ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BMO Equal Weight US Health Care Indx ETF offers a yield of 0.56% to investors and pays a quarterly dividend of $0.25 per share. First Trust NYSE Arca Biotechnology ETF pays -- of its earnings as a dividend. BMO Equal Weight US Health Care Indx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT.TO or ZHU.TO?
First Trust NYSE Arca Biotechnology ETF quarterly revenues are --, which are smaller than BMO Equal Weight US Health Care Indx ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology ETF's net income of -- is lower than BMO Equal Weight US Health Care Indx ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology ETF's price-to-earnings ratio is -- while BMO Equal Weight US Health Care Indx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology ETF is -- versus -- for BMO Equal Weight US Health Care Indx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -- ZHU.TOBMO Equal Weight US Health Care Indx ETF-- -- -- --
-
Which has Higher Returns FBT.TO or ZUH.TO?
BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology ETF's net margin of --. First Trust NYSE Arca Biotechnology ETF's return on equity of -- beat BMO Equal Weight US Health Care Hgd to CAD Idx ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- -
What do Analysts Say About FBT.TO or ZUH.TO?
First Trust NYSE Arca Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand BMO Equal Weight US Health Care Hgd to CAD Idx ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology ETF has higher upside potential than BMO Equal Weight US Health Care Hgd to CAD Idx ETF, analysts believe First Trust NYSE Arca Biotechnology ETF is more attractive than BMO Equal Weight US Health Care Hgd to CAD Idx ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBT.TOFirst Trust NYSE Arca Biotechnology ETF0 0 0 ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF0 0 0 -
Is FBT.TO or ZUH.TO More Risky?
First Trust NYSE Arca Biotechnology ETF has a beta of 0.603, which suggesting that the stock is 39.708% less volatile than S&P 500. In comparison BMO Equal Weight US Health Care Hgd to CAD Idx ETF has a beta of 0.965, suggesting its less volatile than the S&P 500 by 3.481%.
-
Which is a Better Dividend Stock FBT.TO or ZUH.TO?
First Trust NYSE Arca Biotechnology ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BMO Equal Weight US Health Care Hgd to CAD Idx ETF offers a yield of 0.69% to investors and pays a quarterly dividend of $0.49 per share. First Trust NYSE Arca Biotechnology ETF pays -- of its earnings as a dividend. BMO Equal Weight US Health Care Hgd to CAD Idx ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT.TO or ZUH.TO?
First Trust NYSE Arca Biotechnology ETF quarterly revenues are --, which are smaller than BMO Equal Weight US Health Care Hgd to CAD Idx ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology ETF's net income of -- is lower than BMO Equal Weight US Health Care Hgd to CAD Idx ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology ETF's price-to-earnings ratio is -- while BMO Equal Weight US Health Care Hgd to CAD Idx ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology ETF is -- versus -- for BMO Equal Weight US Health Care Hgd to CAD Idx ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBT.TOFirst Trust NYSE Arca Biotechnology ETF-- -- -- -- ZUH.TOBMO Equal Weight US Health Care Hgd to CAD Idx ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
